Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycetoma.

Oliverio Welsh1, Lucio Vera-Cabrera, Mario Cesar Salinas-Carmona

  • 1Dermatology Department, University Hospital, UANL, Monterrey, NL 64460, México. owelsh@yahoo.com

Clinics in Dermatology
|March 14, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous botryomycosis: a comprehensive review.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

Quantitative analysis of lymphocyte exhaustion markers in patients with localized clear cell renal cell carcinoma.

Oncology letters·2025
Same author

UVB radiation impairs CD4+ and IFNγ+ cell responses, promoting IL-10+ cells and exacerbating lesions caused by Leishmania mexicana using a mouse model 30 days post-infection.

Acta tropica·2025
Same author

Ear Sporotrichosis Mimicking Cutaneous Leishmaniasis.

The American journal of tropical medicine and hygiene·2025
Same author

Pre-European contact leprosy in the Americas and its current persistence.

Science (New York, N.Y.)·2025
Same author

Increased expression of the PD-1/PD-L1 regulatory axis in tissue leukocytes from experimental actinomycetoma by Nocardia brasiliensis in BALB/c mice.

Microbial pathogenesis·2025
Same journal

Letter to the editor in reply to "Ethics of Rising Trends in Dermatology Publications Using Large-Scale Databases".

Clinics in dermatology·2026
Same journal

Ethics of suggesting image-guided superficial radiation therapy on the pathology report.

Clinics in dermatology·2026
Same journal

Tanorexia: The Psychodermatology of Compulsive Tanning.

Clinics in dermatology·2026
Same journal

Ear manifestations of connective tissue diseases: A dermatologic, histopathologic, and clinicopathologic review.

Clinics in dermatology·2026
Same journal

Discovery of an intravenous drug injection site: A meticulous cutaneous examination provides the forensic dermatologic clue to a diagnosis of homicide.

Clinics in dermatology·2026
Same journal

Sherlock Holmes and the mystery of the deadly diet.

Clinics in dermatology·2026
See all related articles

Mycetoma is a fungal or bacterial infection affecting the feet, often caused by minor wounds. Treatment varies, with new options explored for drug-resistant cases.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Dermatology

Background:

  • Mycetoma is a chronic granulomatous infection primarily affecting the feet and lower extremities.
  • It is caused by either aerobic actinomycetes (actinomycetoma) or fungi (eumycetoma).
  • Prevalent in tropical and subtropical regions, mycetoma often results from traumatic inoculation via thorns or splinters.

Purpose of the Study:

  • To provide a comprehensive overview of mycetoma, covering its etiology, clinical presentation, and management.
  • To discuss current therapeutic strategies, including antimicrobials and surgery.
  • To explore emerging treatment options for drug-resistant mycetoma.

Main Methods:

  • Review of existing literature on mycetoma.
  • Analysis of clinical manifestations and causative agents.

Related Experiment Videos

  • Evaluation of current and novel treatment modalities.

    • Main Results:

    • Actinomycetomas generally respond well to antimicrobial therapy.
    • Eumycetomas often require surgical intervention.
    • Drug-resistant mycetoma cases necessitate the exploration of new therapeutic avenues.

    Conclusions:

    • Mycetoma management requires a tailored approach based on the causative agent and disease severity.
    • Antimicrobial and surgical treatments remain the cornerstones of therapy.
    • Ongoing research into novel treatments is crucial for addressing drug-resistant mycetoma.